GABA(gamma-Aminobutyric acid) may be used for decreasing anti-gad antibodies and leads beta-cell regeneration.
100 patients with type I diabetes were in 2 groups, had been monitored in a private clinic, number 50 each group, with 30 females and 20 males after the written consent of all patients. All the patients Lied between 18-25 years old with 5-10 years of diabetes onset. The first group was on insulin therapy in the form of toujeo once daily and Novorapid 3 times daily and they received GABA nutritional supplement 750mg per day. The second group was only on insulin injection in the form of toujeo once daily and Novorapid 3 times daily. In the first group;the investigator measured fasting c peptide levels before and after 6 months of GABA 750mg daily.Also,the investigator measured anti gad antibodies before and after 6 months of treatment. In the second group,the investigator measured c peptide levels and anti-gad antibodies at the beginning of the trial and after 6 months.
Study Type
OBSERVATIONAL
Enrollment
100
GABA nutritional supplement 750mg per day for 6 months
Mahmoud Younis
Cairo, Egypt
gaba decrease anti gad antibodies
gaba 750 mg daily for type 1 diabetes patients
Time frame: 6 months
gaba improve c peptide levels
gaba 750 mg pe day for type 1 diabetes patients
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.